MBP metabolic pharmaceuticals limited

Landmark week ahead for surging economyThe biotechnology sector...

  1. 1,154 Posts.
    Landmark week ahead for surging economy

    The biotechnology sector will be sweating on Metabolic Pharmaceuticals' imminent announcement about the phase II clinical trial of its potential blockbuster drug for obesity treatment.

    The result was due last week, but reviewing extensive data from the 300-patient trial has taken longer than expected. Metabolic's share price has weakened in recent weeks.

    G
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.